Gene Editing Archives - Page 2 of 4 - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Generating Over a Billion Cells with CRISPR for Next Generation Cell Therapies

August 29, 2022

Leveraging Patent Intelligence and Network Analysis to Quantify Technology Influence in CRISPR

Using CRISPR interference (CRISPRi) Viability Screens to Map Long Noncoding RNA Dependencies in Tumor Cells

Flexible & Scalable Genetic Screens for Novel Therapeutic Target Discovery: An Overview of Noteworthy Case Studies

January 20, 2022

Epigenetic Editing with CRISPR + ADHD in Preschoolers – Xtalks Life Science Podcast Ep. 10

A New Platform for Clinical Gene Editing of iPSCs to Make Clonal Cell Banks

February 25, 2021

Establishing New Standards in Efficient Single Cell Cloning of hiPSCs

September 22, 2020

A Look at America’s First CRISPR Clinical Trial

November 11, 2019

Prime Editing Could Correct 89 Percent of Disease-Causing Mutations

October 28, 2019

Life Sciences Quizzes & Polls

What Do You Know About Medical Biotechnology?

October 25, 2019

New CRISPR Gene Editing Enzyme Removed Duchenne Muscular Dystrophy Mutations

September 17, 2018

Sangamo Therapeutics to Buy TxCell to Combine Gene Editing and CAR-T Technologies

Eliminating the Viral Vector Makes CRISPR Gene Editing More Versatile

Using CRISPR to Correct Clusters of Duchenne Muscular Dystrophy Mutations

February 1, 2018

Vertex Pharmaceuticals and CRISPR Therapeutics to Co-Develop Sickle Cell Treatment

December 27, 2017

CRISPR May Not be Magic Bullet: Will Gene Editing Need to be Personalized?

December 13, 2017

Next Page »